arachnoid cyst

Arachnoid cysts are relatively common benign and asymptomatic lesions occurring in association with the central nervous system, both within the intracranial compartment (most common) as well as within the spinal canal. They are usually located within the subarachnoid space and contain CSF.

On imaging, they are characterized as well circumscribed cysts, with an imperceptible wall, displacing adjacent structures, and following the CSF pattern (hypodense on CT and hyperintense on T2 with FLAIR suppression on MRI). They can also have a remodeling effect on the adjacent bone.

Epidemiology

Arachnoid cysts account for ~1% of all intracranial masses. Although the vast majority are sporadic, they are seen with increased frequency in mucopolysaccharidoses (as are perivascular spaces).

In a retrospective cohort study of 48,417 patients who underwent neuroimaging, arachnoid cysts were identified in 661 patients (1.4%) with a statistically significant male predilection .

Clinical presentation

The majority of arachnoid cysts are small and asymptomatic. Approximately 5% of patients experience symptoms and when symptoms occur, they are usually the result of gradual enlargement resulting in mass effect . This results in either direct neurological dysfunction or distortion of normal CSF pathways resulting in obstructive hydrocephalusSellar/suprasellarquadrigeminal, and cerebellopontine angle arachnoid cysts were more likely to be symptomatic .

Genetics

Arachnoid cysts are almost always sporadic and nonsyndromic, but association with acrocallosal, Aicardi, and Pallister-Hall syndromes have been reported .

Pathology

Arachnoid cysts are thought to arise due to the congenital splitting of the arachnoid layer with accumulation of CSF within this potential space. The cyst wall is comprised of flattened arachnoid cells forming a thin translucent membrane. There is no solid component and no epithelial lining.

Radiographic features

Arachnoid cysts can occur anywhere within the central nervous system, most frequently (50-60%) located in the middle cranial fossa, where they invaginate into and widen the Sylvian fissure. In this location, they can be classified into three types based on their size: see Galassi classification. Of these, Galassi type I is most common accounting for 78% followed by Galassi II and III with 19% and 3% respectively . The retrocerebellar location accounts for 30-40% of arachnoid cysts .

Some locations deserve special mention and separate discussion:

CT

Arachnoid cysts are extremely well circumscribed, with an imperceptible wall, and displace adjacent structures. When large, and over time, they can exert a remodeling effect on the bone.

CT cisternography (introduction of contrast into the subarachnoid space) demonstrates communication of the cyst with the subarachnoid space. As this communication is slow, the cyst often fills later, and contrast may be seen to pool with it, outlining its dependent portion.

MRI

As they are filled with CSF, it is not surprising that they follow CSF on all sequences, including FLAIR and DWI. This enables them to be distinguished from epidermoid cysts for example. As their wall is very thin it only occasionally can be seen, and displacement of surrounding structures implies their presence. As there is no solid component, no enhancement can be identified.

Phase contrast imaging can also be employed not only to determine if the cyst communicates with the subarachnoid space, but also to identify the location of this communication.

Magnetic resonance cisternography: high resolution sequences such as CISS & FIESTA help to delineate cyst wall and adjacent anatomic structures.

Treatment and prognosis

Arachnoid cysts are benign, and the vast majority remain asymptomatic throughout life. If they are deemed to be causing symptoms, then surgery can be contemplated. This can either take the form of a craniotomy (fenestration or excision) or placement of a cystoperitoneal shunt.

A rare complication is spontaneous rupture in the subdural space .

History and etymology

Richard Bright was the first to describe an arachnoidal cyst in 1831 .

Differential diagnosis

General imaging differential considerations include:

See also

Siehe auch:
und weiter: